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A B S T R A C T
Health-related quality of life (HRQoL) among hemodialysis (HD) patients recently became a nephrologist’s focus of
interest. HRQoL is an important predictor of outcome in HD patients and need to be regularly assessed. The aim of the
present study was to compare the HRQoL of chronic HD patients with general population and to analyze influencing
sociodemographic and clinical factors. We included 255 prevalent HD patients from four dialysis centers. HRQoL was
measured with The Medical Outcomes Study Short Form 36 Health Survey Questionnaire (SF-36). This data were com-
pared with control group (N=132) from the general Croatian population. Comparisons of SF-36 scale scores of HD pa-
tients regarding demographic and clinical factors (age, gender, education level, dialysis vintage and diabetes) were also
performed and analyzed with a multivariate regression analysis. HRQoL in prevalent HD patients was relatively low
(mean Physical Component Summary, PCS=33.7, mean Mental Component Summary, MCS=43.0) and was lower com-
pared to the control group from the general population in all HRQoL domains, PCS and MCS scores. Almost 53% of the
HD patients had the critical score PCS<43 + MCS<51 as the predictor of death and hospitalization. Better HRQoL was
revealed in the patients <65 years old, males, patients with higher educational level and in the patients on maintenance
HD less than one year. Age was the only statistically significant predictor of PCS and MCS. Developments of HD technol-
ogy, treatment of comorbidities, continuous patients’ education, social and psychological support and use of other renal
replacement modalities, especially kidney transplantation, may improve the HRQoL in these patients.
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Introduction
In recent years, health-related quality of life (HRQoL)
in end-stage renal disease (ESRD) patients has become a
focus of interest in evaluating various modalities of renal
replacement therapy (RRT)1–4. In addition to mortality
and morbidity, HRQoL assessment has become also an
important outcome measure in the evaluating quality
and effectiveness of medical care in ESRD1,5. The concept
of HRQoL explores the impact of disease and healthcare
on patients, their functional status and their self-related
health6.
Several studies on ESRD patients have reported im-
pairment in HRQoL in hemodialysis (HD) patients1,7.
Recent reports have shown that questionnaire-derived
assessment of HRQoL is a strong and independent pre-
dictor of mortality and morbidity in HD patients5,8–11.
The Dialysis Outcomes and Practice Patterns Study
(DOPPS) concluded that a 10-point lower PCS of SF-36
was associated with higher elevation in the mortality
risk than 1g/dL lower serum albumin level5. There is evi-
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dence that a mental component of HRQoL predicts death
and hospitalization in HD patients8. The HRQoL assess-
ment may be applied to identify an individual’s risk for
important outcomes, such are death and hospitalization.
Considering this facts, evaluation of HRQoL in the main-
tenance HD patients and analysis of the factors which
have an influence to it, is an important objective.
According to the World Health Organization defini-
tion, quality of life (QoL) is a multidimensional category
comprising physical, mental, social and economic com-
ponents12. Many factors can influence QoL, including de-
mographic, medical and psychological parameters. Dif-
ferent generic and disease-specific questionnaires have
been used for assessing the QoL in patients with ad-
vanced kidney disease13. Depending on the method used,
various factors are identified as predictors of good or bad
QoL. The Medical Outcomes Study Short Form 36 Heal-
th Survey (SF-36) is generic QoL assessment instrument
widely used to measure HRQoL in ESRD patients6,14.
The SF-36 is a patient-related questionnaire that in-
cludes assessment of physical function, social function,
limitations due to physical health, limitations due to
mental health, vitality, bodily pain and general health15.
By investigating these eight dimensions, two final scores
can be calculated: physical component summary (PCS)
and mental component summary (MCS). According to
that, the SF-36 allows comparison of QoL measured in
individual patient with general population and among
patients treated with methods of RRT16–19. SF-36 final
summary scores can be used as an additional factor for
economic evaluation. Moreover, this self-assessment re-
port provides the information that may not be possible
through other method8.
ESRD is a growing public health concern. Relevant
studies regarding HRQoL assessment in HD patients in
Croatia have not been performed previously.
The aim of present study was to investigate the HRQoL
of chronic HD patients in the North-Adriatic region and
to compare it with HRQoL of control group from the gen-
eral population. Furthermore, our aim was to analyze
sociodemographic and clinical factors influencing HRQoL
in the maintenance HD patients in this region and com-
pare our results with those from similar researches.
Subjects and Methods
Subjects
A total of 255 prevalent HD patients (male 53.7%, age
65.1±12.5 years) were included in this study as patient
group. Patients were drawn from one hospital HD center
(Rijeka, N=170) and three smaller out-patient HD cen-
ters (Umag, N=40; Labin, N=30; Delnice, N=15) in the
North-Adriatic region of Croatia. All patients have been
at least three month on dialysis which was performed
three times a week, all on polysulphone dialysers. Exclu-
sion criteria were congestive heart failure, severe chronic
liver disease, acute infection, malignancy, pregnancy or
breastfeeding and cognitive impairment. The data were
collected in 2008 and 2009.
Demographic (age, gender and education level), clini-
cal data (HD duration and systolic arterial blood pres-
sure) and biochemical parameters (hemoglobin, urea,
creatinine, albumin and Kt/V) were abstracted from the
patients’ medical records at the time of enrollment.
The control group consisted of 132 persons without
diagnosed any chronic kidney or mental disease. The par-
ticipants were recruited in the family medicine units of
Rijeka Medical Center. The control group matched the
patient group in age and gender.
The study was approved by the Hospital’s Ethical
Committee. A written informed consent was obtained
from all participants.
Methods
Each participant completed the SF-36 questionnaire
form. The SF-36 is a 36-item questionnaire for assess-
ment of HRQoL15. The SF-36 consists of eight dimen-
sions: physical functioning, physical role limitations, ge-
neral health perceptions, bodily pain, vitality, emotional
role limitations, mental health and social functioning.
The first four sub-scales can be combined as the PCS and
last four as the MCS score. All sub-scales as well as the
summary components are presented as scores between 0
and 100, with higher score indicating better HRQoL. The
validity of the SF-36 has been tested in patients with re-
nal disease, including kidney transplant recipients6,14.
The SF-36 questionnaire has been validated in the Cro-
atian population16,17. A demonstration of the SF-36 can
be found at http://www.sf-36.org/demos/SF-36.html.
The questionnaire was self-administered and com-
pleted during regular HD session or during visits to fam-
ily medicine unit.
Statistics
Statistical analysis was performed using Statistical
Package for Social Sciences for Windows version 11.0
(SPSS Inc., Chicago, IL, USA).
Results from quantitative variables are expressed as
mean±standard deviation (X±SD), results from qualita-
tive variables are expressed as percentages. Intergroup
differences were analyzed and compared using Student’s
t-test. The correlation between HRQoL sub-scales and
continuous variables (age, hemoglobin and HD duration)
was determined using linear regression analysis.
Multiple regression analysis was performed to analy-
ze the relation between hemoglobin, albumin, HD treat-
ment vintage, level of education and age with PCS and
MCS HRQoL measure. A value for p<0.05 was consid-
ered statistically significant.
Results
Demographic and clinical data of the patient group
are presented in Table 1. In our study population 54.1%
were aged 65 years. The predominant cause of end-
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-stage renal disease was diabetes (26.5%). There were not
any statistically significant differences between the HD
patients and the controls regarding age and gender.
Mean scores of the HRQoL domains of the HD pa-
tients and control group are presented in Figure 1. The
mean scores of all eight sub-scales of SF-36 were lower in
HD patients compared with those found in controls. The
results of cut-off scores for PCS and MCS (predictors of
death and hospitalization PCS<43, MCS<51 and de-
pression MCS<43)8,20 are presented in Table 2. Con-
sidering these criteria, we found a PCS<43 in 74.0% of
patients, a MCS<51 in 67.8% of patients and PCS<43+
MCS<51 in 52.7% of patients. A cut-off value for depres-
sion MCS<43 had 45.9% of patient. Among HD patients
aged 65 years, the analyzed scores were found in 83.5;
77.7; 63.3 and 53.2% respectively.
Comparisons of SF-36 scale scores by demographic
and clinical factors are shown in Tables 3 and 4. Patients
aged 65 years scored significantly lower in all HRQoL
dimensions, PCS and MCS. Scores for all HRQoL dimen-
sion were lower in female patients, but statistically sig-
nificant difference was found only for role physical (p=
0.023) and mental health (p=0.036), while for vitality
and PCS the significance was on level p=0.05. Compari-
son of SF-36 scores by education level demonstrated a
significant influence in all HRQoL dimensions, including
PCS and MCS. Patients with medium or high education
level (>8 years) had significantly higher SF-36 scores
than patients with low education level (8 years). Ana-
lyzing the HD duration, the significant difference was
found in only two dimension of HRQoL. Patients who
started dialysis more than one year ago scored lower for
physical functioning (p=0.042) and social functioning
(p=0.046). There were no significant differences in HRQoL
scores by the presence of diabetes in HD patient group
(Table 5).
Table 6 summarizes the results from the linear re-
gression analysis. PCS, MCS and all SF-36 domains ex-
cept general health were found to be influenced nega-
tively by age, while role physical, vitality, role emotional
and MCS were influenced positively by years of educa-
tion. Role physical, general health and vitality correlated
positively with Hb.
The effects of Hb, albumin, HD duration, level of edu-
cation and age on PCS were tested by multiple regression
analysis. PCS was predicted only by age (R2=0.15; b=
–0.32; p<0.001). The same predictors were correlated
with MCS as dependent variable. The results showed
that MCS was significantly predicted also only by age
(R2=0.075; b=–0.174; p<0.05).
Discussion
The aim of the present study was to examine the
HRQoL in maintenance HD patients in the North-Adri-
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TABLE 1
DEMOGRAPHIC AND CLINICAL CHARACTERISTIC OF PATIENTS
ON CHRONIC HEMODIALYSIS (N=255)
Variable
Age (years, X±SD) 65.1±12.5
Gender (% males) 49.1
Living alone (%) 16.7
Education (years, X±SD) 9.4±3.9
HD duration (months, X±SD) 92.8±45.6
Kt/V (X±SD) 1.23±0.25
Hb (g/L, X±SD) 109.65±13.1
Albumin (g/L, X±SD) 40.19±6.6
Predialysis systolic BP (mmHg, X±SD) 140.0±19.8
Predialysis urea (mmol/L, X±SD) 23.8±5.3
Predialysis creatinine (mmol/L, X±SD) 835.0±243.9
Currently on the transplantation waiting list (%) 25.1













*HD – hemodialysis, Kt/V – delivered dialysis dose, Hb – hemo-
globin, X – mean, SD – standard deviation
TABLE 2
CUT-OFF HEALTH-RELATED QUALITY OF LIFE SCORES IN
HEMODIALYSIS PATIENTS [PREDICTORS OF DEATH AND
HOSPITALIZATION: PHYSICAL COMPONENT SUMMARY<43,
MENTAL COMPONENT SUMMARY<518 AND PREDICTOR OF





<65 years (%) 62.7 59.7 40.3 37.3
65 years (%) 83.5 77.7 63.3 53.2
Total (%) 74.0 67.8 52.7 45.9

































Fig. 1. Comparison of SF-36 scores in hemodialysis patients and
controls. Statistically significant difference (p<0.001) was obser-
ved between hemodialysis patients and control group for all tes-
ted parameters.
atic region of Croatia and to analyze sociodemographic
and clinical factors influencing HRQoL in this patient
group.
To our knowledge, this is the first report of HRQoL in
Croatian HD patients using SF-36 questionnaire. Our
study demonstrated that HRQoL of patients on chronic
HD is severely impaired compared to the control group
without kidney disease from the general population. In
that way, we assessed the impact of ESRD and renal re-
placement therapy on patients’ perception of health. Our
results showed relatively low HRQoL in the sample of
prevalent HD patients, similar to previous published
studies1,18,19. As expected, HD patients demonstrated lo-
wer HRQoL status than the controls from the general
population. HD patients scored lower in all physical, so-
cial and mental HRQoL domains, as in PCS and MCS
scores. These results are consistent with data from other
comparable national studies in HD patients21,22.
Table 7 shows HRQoL summary scores of HD pa-
tients from the North-Adriatic region of Croatia and
those from several international studies. Comparing to
HD patients enrolled in DOPPS and Russian study, Cro-
atian HD patients had lower PCS and almost equal
MCS1,19. The difference between our study population
and HD patients from Romania was even more pro-
minent18. A possible explanation for the differences in
PCS is the fact that our population was older than the
patients enrolled in DOPPS (65.1 versus 59.9 years), in
Russian (43.5 years) and Romanian study (51.7 years).
The results of previous studies on HRQoL showed that
age have a negative impact on PCS in HD patients1,13,22.
Mingardi et al. reported that aging had a negative effect
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TABLE 3












Physical functioning 39.6±10.1 30.3±13.6 <0.001 32.7±12.9 36.4±12.9 0.080
Role physical 41.3±12.3 33.1±10.1 <0.001 34.6±10.5 39.0±12.7 0.023
Bodily pain 47.0±12.3 37.4±12.4 <0.001 39.9±12.4 43.7±13.9 0.088
General health 33.6±9.6 29.2±7.7 0.003 30.9±8.4 31.5±9.4 0.694
Vitality 46.6±9.8 40.5±10 <0.001 41.7±9.9 45.0±10.6 0.050
Social functioning 42.5±9.4 34.7±12 <0.001 36.8±11.1 39.7±11.8 0.121
Role emotional 45.3±13.1 38.9±14.2 0.005 40.6±13.8 43.1±14.2 0.285
Mental health 43.3±10.8 37.7±12.5 0.005 38.2±11.1 42.4±12.6 0.036
Physical component summary 39.1±9.2 30.4±10.8 <0.001 32.8±10.6 35.9±11.2 0.051
Mental component summary 46.1±10.8 41.3±12.8 0.016 42.1±11.7 44.9±12.4 0.156
*X – mean, SD – standard deviation
TABLE 4
COMPARISON OF SF-36 SCORE IN HEMODIALYSIS PATIENTS BY EDUCATION LEVEL AND HEMODIALYSIS TREATMENT VINTAGE










Physical functioning 39.2±12 30.3±12.4 <0.001 38.9±10.1 33.8±13.3 0.042
Role physical 42.0±12.3 32.2±9.2 <0.001 38.6±9.7 36.5±12.1 0.381
Bodily pain 45.1±13.6 38.8±2.2 0.005 42.0±11.1 41.7±13.6 0.908
General health 34.0±9.5 28.6±7.5 <0.001 30.1±7.6 31.4±9.1 0.459
Vitality 47.8±10.1 39.4±8.8 <0.001 42.7±9.3 43.5±10.5 0.718
Social functioning 42.6±10.3 34.3±11.2 <0.001 41.8±9.1 37.6±11.8 0.047
Role emotional 47.3±12.2 37.0±13.8 <0.001 44.7±12.9 41.2±14.2 0.250
Mental health 45.0±11.3 36.0±11.1 <0.001 41.0±9.1 40.1±12.5 0.709
Physical component summary 38.0±10.9 31.1±10.0 <0.001 36.4±8.9 34.1±11.3 0.282
Mental component summary 48.3±11.0 39.3±11.6 <0.001 44.5±10.5 43.3±12.4 0.629
*X – mean, SD – standard deviation
on HRQoL with more evident impact on physical do-
mains22. The prevalence of diabetes was 26.5% in our HD
patients group, while the prevalence was lower in DOPPS,
Russian and Romanian sample (13.8; 3.5 and 8.2% re-
spectively)1,18,19. This finding reflects the facts that co-
hort of diabetic patients treated with HD in the North-
-Adriatic region of Croatia is large and that diabetes has
become the main cause of ESRD24. Diabetes has been as-
sociated with poorer HRQoL in HD patients as reported
in the study performed by Lopez Reuvelta et al.9. How-
ever, in our study diabetes did not impact on the SF-36
scores.
Our results demonstrated that MCS scores were hi-
gher than PCS scores, similar findings were presented in
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TABLE 5
COMPARISON OF SF-36 SCORES IN DIABETIC AND NONDIABETIC HEMODIALYSIS PATIENTS
Diabetic HD patients X±SD Nondiabetic HD patients X±SD p
Physical functioning 30.7±12.9 35.5±12.4 0.076
Role physical 36.3±12.1 37.0±10.4 0.758
Bodily pain 40.6±13.6 42.0±11.5 0.569
General health 29.9±8.9 31.5±8.9 0.373
Vitality 42.2±10.8 43.6±7.6 0.426
Social functioning 38.0±11.3 38.3±12.4 0.911
Role emotional 43.7±13.9 41.3±14.6 0.426
Mental health 39.0±12.5 40.5±9.4 0.484
Physical component summary 32.4±11.4 34.9±9.1 0.215
Mental component summary 44.3±12.3 43.2±11.3 0.662
*HD – hemodialysis, X – mean, SD – standard deviation
TABLE 6
CORRELATION BETWEEN HEALTH-RELATED QUALITY OF LIFE SUB-SCALES OF HEMODIALYSIS PATIENTS, PHYSICAL COMPONENT
SUMMARY, MENTAL COMPONENT SUMMARY AND AGE, YEARS OF EDUCATION AND HEMOGLOBIN DETERMINED BY LINEAR
REGRESSION ANALYSIS
Age (years) Years of education (years) Hemoglobin (g/L)
R2 b p R2 b p R2 b p
Physical functioning 0.125 –0.391 <0.001 0.010 0.329 0.280 0.031 0.152 0.048
Role physical 0.127 –0.353 <0.001 0.036 0.564 0.038 0.005 0.057 0.422
Bodily pain 0.104 –0.350 <0.001 0.008 0.294 0.327 0.002 0.037 0.631
General health 0.021 –0.104 0.118 0.013 0.252 0.211 0.035 0.107 0.041
Vitality 0.082 –0.241 0.001 0.061 0.627 0.006 0.038 0.127 0.033
Social functioning 0.125 –0.345 <0.001 0.026 0.476 0.077 0.024 0.118 0.090
Role emotional 0.079 –0.332 0.002 0.036 0.679 0.037 0.007 0.075 0.378
Mental health 0.052 –0.222 0.012 0.022 0.439 0.103 0.006 0.058 0.408
Physical component summary 0.134 –0.328 <0.001 0.009 0.263 0.290 0.019 0.097 0.128
Mental component summary 0.051 –0.226 0.013 0.041 0.611 0.026 0.009 0.073 0.304
TABLE 7
COMPARISON OF PHYSICAL COMPONENT SUMMARY SCORES AND MENTAL COMPONENT SUMMARY SCORES IN DIFFERENT
HEMODIALYSIS POPULATION
Germin et al. Seica et al.18 Fukuhara et al.1 Vasilieva19
Patients 255 606 2406 1047
Mean age 65.1 51.7 59.9 43.5
PCS 33.7 46.3 35.5 36.9
MCS 43.0 55.1 43.2 44.2
* PCS – Physical Component Summary; MCS – Mental Component Summary
other studies in HD patients19,22,23. This could be the re-
sult from the use of adaptive coping strategies and dy-
namic adaptation of patients’ expectations to their chro-
nic illness21,25. The difference between PCS and MCS
scores point at relatively preserved mental health of dial-
ysis patients despite the worsening of the physical health
status.
A half of the HD population enrolled in our study
have critical, both PCS and MCS scores, correlated with
increased risk of death and hospitalization. Lowrie et al.
reported a higher risk for death and hospitalization in
HD patients having the critical scores, a one-point in-
crease in PCS is associated with a 2% reduction in mor-
tality, independently of demographic and comorbid va-
riables8. This facts could be a consequence of a high
proportion of patients aged 65 years in our HD popula-
tion. The proportion of elderly people in Croatian HD
population has recently become a significant issue be-
cause the median of age of Croatian HD patients in 2008
was 67 years25. A possible explanation for the low score of
PCS lies in the fact that the functional impairment and
disability in elderly HD patients was found to be higher
than in age-matched controls, as stated by Altintepe et
al.26. Moreover, Altintepe et al. reported higher depres-
sion and anxiety symptoms score in elderly HD patients
and lower MCS compared to age-matched controls26. The
prevalence of depression detected by critical score of
MCS43, established by DeOreo et al., was higher than
that reported by Seica et al.18,20. Previous studies re-
ported that older age and depression level were associ-
ated with PCS negatively and that the depression level
was a significant and independent predictor of both PCS
and MCS19. This means that the presence of depression
has a significant impact on both physical and mental as-
pects of HRQoL. Furthermore, the lower educational
level and income of elderly patients on maintenance HD
are the conditions that could be associated with lower
HRQoL27. In agreement with these findings are our re-
sults that demonstrated the significant negative correla-
tion of age on almost all domains of HRQoL, including
PCS and MCS.
In our study women reported lower HRQoL scores
then men, as already stated in other studies18,22,28. Wo-
men had significantly lower scores in role physical and
mental health domains, while for vitality and PCS the
significance level was p=0.05. These results suggest that
women with chronic illness might have lower levels of so-
cial support in their everyday activities.
Results from our study showed that a 8 years of edu-
cation was associated with lower HRQoL. HD patients
with 8 years of education scored lower in all domains
and summary scores than those with >8 years. This find-
ing agree with results of Mingardi et al. and Rebollo et al.
who also found a significant association between low ed-
ucational level and low HRQoL22,28. The possible expla-
nation is that lower educational level is usually associ-
ated with lower income and, as a consequence, with
lower HRQoL.
An interesting result found in our HD patients was
lower scores in physical and social functioning in pa-
tients dialyzed for more than one year. This may be ex-
plained by the impact of the chronic illness and HD treat-
ment regiments interfering on QoL.
In the present study, age had a negative impact on
both PCS and MCS, that is in agreement with previous
studies18,19. Using multiple regression analysis, age was
the only statistically significant predictor of PCS (p<
0.001) and MCS (p<0.05), accounting for 15% of the vari-
ance for PCS and 7.5% variance for MCS. These results
strongly suggest that age is an important contributor to
low HRQoL in the HD patients in North-Adriatic region
of Croatia. In addition, obtained results also emphasize
that HRQoL is influenced by different still unrecognized
factors and that HD patients should deserve further psy-
chological and social attention. Depression is identified
as the most common mental problem in patients on
chronic hemodialysis and a powerful predictor of quality
of life29,30. Both clinically diagnosed depression and pres-
ence of depressive symptoms are associated with im-
paired HRQoL in this patient population. Hearing im-
pairment is also frequent in ESDR patients, particularly
sensorineural hearing loss31. Moreover, these disorders
are rarely diagnosed and insufficiently treated.
Several limitations of our study should be noted. A
relatively small number of patients enrolled, older age
and high percentage of diabetic patients should be con-
sidered while interpreting the results of our study. How-
ever, the results reflect the fact that all the patients on
chronic HD in dialysis centers Rijeka, Umag, Labin and
Delnice were included in the study. The specific demo-
graphic and clinical features of the studied population
are in agreement to the data presented in Croatian Reg-
istry for Renal Replacement Therapy23. In spite of these
limitations, our results can be compared with most of the
studies that analysed QoL in HD patients.
In conclusion, our study shows that HRQoL in the
HD patients in the North-Adriatic region is lower com-
pared with the general population. Several sociodemo-
graphic and clinical variables, as older age, female gen-
der, low educational level and more than one year of HD
treatment are associated with lower HRQoL. The older
age was found as the only independent negative predic-
tor for both PCS and MCS. Further studies are needed to
better understand the influence of other factors on HRQoL
and to develop interventions to improve HRQoL in ESRD
patients.
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KVALITETA @IVOTA UVJETOVANA ZDRAVLJEM U BOLESNIKA NA REDOVITOJ HEMODIJALIZI –
ANALIZA DEMOGRAFSKIH I KLINI^KIH ^IMBENIKA
S A @ E T A K
Kvaliteta `ivota uvjetovana zdravljem (»Health-related Quality of Life – HRQoL«) u bolesnika na redovitoj hemo-
dijalizi (HD) odnedavno je u fokusu interesa nefrologa. HRQoL je potrebno redovito procjenjivati, jer predstavlja va`an
prediktor ishoda lije~enja u HD bolesnika. Cilj ovog istra`ivanja bio je usporediti HRQoL bolesnika na redovitoj HD s
op}om populacijom te analizirati utjecaj sociodemografskih i klini~kih ~imbenika na HRQoL. U istra`ivanje je uklju-
~eno 255 bolesnika iz ~etiri centara za dijalizu. HRQoL je mjerena kori{tenjem »Medical Outcomes Study Short Form
36 Health Survey« upitnika (SF-36). Ovi podaci su uspore|eni s kontrolnom skupinom (N=132) iz op}e hrvatske popu-
lacije. Osim usporedbe SF-36 samoprocjenske skale bolesnika na HD s obzirom na razli~ite demografske i klini~ke
~imbenike (dob, spol, stupanj obrazovanja, trajanje lije~enja dijalizom i prisustvo {e}erne bolesti), izvr{ena je i multiva-
rijatna regresijska analiza navedenih parametara. HRQoL u bolesnika na HD bila je relativno niska (srednje vrijednosti
»Physical Component Summary« – PCS=33,7, »Mental Component Summary« – MCS=43,0) te ni`a u usporedbi s
kontrolnom skupinom iz op}e populacije u svim domenama HRQoL, PCS i MCS rezultatima. Gotovo 53% bolesnika
lije~enih HD imalo je kriterije PCS<43 i MCS<51, koji predstavljaju prediktore ve}e smrtnosti i ~e{}ih hospitalizacija.
Bolja HRQoL je zabilje`ena kod bolesnika <65 godina, mu{karaca, bolesnika sa vi{im stupnjem obrazovanja te u bole-
snika lije~enih HD kra}e od jedne godine. Starija dob je bila jedini neovisni prediktor PCS i MCS. Razvoj dijalizne
tehnologije, lije~enje pridru`enih bolesti, kontinuirana edukacija bolesnika, socijalna i psiholo{ka podr{ka te kori{tenje
drugih metoda nadomje{tanja bubre`ne funkcije, osobito transplantacije bubrega, mo`e pobolj{ati HRQoL u ovoj popu-
laciji bolesnika.
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